SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLSD - Clearside BioMedical
CLSD 4.030+7.8%1:34 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BioHero2/11/2019 9:30:56 AM
   of 17
 
Clearside Biomedical, Inc. (CLSD): Outperform Candidate With 330.88% Upside Potential

Clearside Biomedical, Inc. is maintained at an average outperform rating by 8 stock analysts, and there are at least 2.8% of shares outstanding that are currently legally short sold. The shares went up by 15.25% in value last month. Year-to-date it jumped 27.1%. Analysts are turning out to be more optimistic than before, with 5 of analysts who cover Clearside Biomedical, Inc. (NASDAQ:CLSD) advice adding it to buy candidate list. Wall Street experts also assign a $5.86 price target on Clearside Biomedical, Inc., pointing towards a 330.88% rally from current levels. The stock is trading for about -91.13% less than its 52-week high.

postanalyst.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext